ScoreWhy is Natco Pharma Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.91% and Operating profit at 15.18% over the last 5 years
2
With a fall in PBT of -50.2%, the company declared Very Negative results in Jun 26
- The company has declared negative results for the last 3 consecutive quarters
- NET SALES(Q) At Rs 735.20 cr has Fallen at -27.9% (vs previous 4Q average)
- PBT LESS OI(Q) At Rs 126.40 cr has Fallen at -57.6% (vs previous 4Q average)
- PAT(Q) At Rs 206.50 cr has Fallen at -41.8% (vs previous 4Q average)
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Natco Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Natco Pharma
-0.52%
-0.02
36.64%
Sensex
-9.27%
-0.68
13.51%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.91%
EBIT Growth (5y)
15.18%
EBIT to Interest (avg)
54.00
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.52
Tax Ratio
8.21%
Dividend Payout Ratio
5.70%
Pledged Shares
0
Institutional Holding
22.61%
ROCE (avg)
21.62%
ROE (avg)
16.51%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
38
Price to Book Value
1.63
EV to EBIT
15.92
EV to EBITDA
12.96
EV to Capital Employed
1.75
EV to Sales
3.91
PEG Ratio
NA
Dividend Yield
0.54%
ROCE (Latest)
15.76%
ROE (Latest)
15.38%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 4.63 times
-30What is not working for the Company
NET SALES(Q)
At Rs 735.20 cr has Fallen at -27.9% (vs previous 4Q average
PBT LESS OI(Q)
At Rs 126.40 cr has Fallen at -57.6% (vs previous 4Q average
PAT(Q)
At Rs 206.50 cr has Fallen at -41.8% (vs previous 4Q average
INTEREST(9M)
At Rs 33.40 cr has Grown at 26.04%
ROCE(HY)
Lowest at 15.37%
DEBT-EQUITY RATIO(HY)
Highest at 0.08 times
Loading Valuation Snapshot...
Here's what is working for Natco Pharma
Debtors Turnover Ratio- Half Yearly
Highest at 4.63 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Natco Pharma
Net Sales - Quarterly
At Rs 735.20 cr has Fallen at -27.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 1,019.58 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 126.40 cr has Fallen at -57.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 298.30 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 206.50 cr has Fallen at -41.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 354.63 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Nine Monthly
At Rs 33.40 cr has Grown at 26.04%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 0.08 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
